203 related articles for article (PubMed ID: 33044577)
1. [Microbiota and multiple sclerosis].
Gerdes LA; Yoon H; Peters A
Nervenarzt; 2020 Dec; 91(12):1096-1107. PubMed ID: 33044577
[TBL] [Abstract][Full Text] [Related]
2. Feeding the gut microbiome: impact on multiple sclerosis.
Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
5. Disease of the holobiont, the example of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Med Clin (Barc); 2019 Feb; 152(4):147-153. PubMed ID: 30424933
[TBL] [Abstract][Full Text] [Related]
6. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
8. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
[TBL] [Abstract][Full Text] [Related]
9. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
10. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models.
Moles L; Egimendia A; Osorio-Querejeta I; Iparraguirre L; Alberro A; Suárez J; Sepúlveda L; Castillo-Triviño T; Muñoz-Culla M; Ramos-Cabrer P; Otaegui D
ACS Chem Neurosci; 2021 Mar; 12(5):893-905. PubMed ID: 33566588
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
Front Immunol; 2018; 9():942. PubMed ID: 29770137
[TBL] [Abstract][Full Text] [Related]
14. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
15. The role of the gut microbiota and microbial metabolites in neuroinflammation.
Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
[TBL] [Abstract][Full Text] [Related]
17. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
[No Abstract] [Full Text] [Related]
18. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria.
Wekerle H
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii68-ii75. PubMed ID: 27856664
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
Fettig NM; Osborne LC
Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
[TBL] [Abstract][Full Text] [Related]
20. Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Melnikov M; Sviridova A; Rogovskii V; Oleskin A; Boziki M; Bakirtzis C; Kesidou E; Grigoriadis N; Boykо A
Mult Scler Relat Disord; 2021 Jun; 51():102888. PubMed ID: 33756440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
